Skip to main content
SpringerLink
Log in

Rituximab

Development of rituximab resistance in primary bone marrow diffuse large B-cell lymphoma: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wang W, et al. Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP. Immunotherapy 9: 379-385, No. 5, Mar 2017. Available from: URL: http://doi.org/10.2217/imt-2017-0005 -China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rituximab. Reactions Weekly 1659, 269 (2017). https://doi.org/10.1007/s40278-017-32927-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-32927-z

Search

Navigation